knowledge -WSS

knowledge

author：comprehensive 2025-10-04 11:31:10 - browse：9134

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： WHO may add ‘noma' to its list of neglected tropical diseases

WSS

Hospitals are piloting generative AI tools as regulators play catch

Biden's order seeks to regulate AI risk without stifling innovation

As AI regulations shape up, health tech startups beg for clarity

Telehealth options flood the market as retailers push virtual care

Flagship Pioneering startup Sonata Therapeutics lays off 21

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

knowledge

Heart attack and stroke risk calculators need revising

Ukraine seeks to reclaim its role as a hub for clinical trials

In Memoriam: Notable people who died in 2023

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Drug repurposing or repositioning? The language matters

Weight loss drugs aren’t covered by Obamacare. That may change

Malaria cases in Florida and Texas: Here’s what you need to know

First Opinion Podcast: How to protect health care in times of war

Medical records are filled with copy

CDC recommends rationing of RSV shot due to shortages

hotspot

New study raises questions about niacin and heart health

A new drug could help frostbite victims avoid its ravages

Senate panel to vote on hospitals, PBMs, prisoner care

Elevance, SCAN deals highlight health insurer acquisition scrutiny

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

The FDA weighs the risks of candy

hotspot

knowledge

Wikipedia

focus